A resolution designating the week of May 5, 2024, through May 11, 2024, as "Tardive Dyskinesia Awareness Week".

This resolution designates May 5-11, 2024, as "Tardive Dyskinesia Awareness Week" to highlight a movement disorder caused by long-term use of certain medications (like antipsychotics). It directly affects approximately 600,000 U.S. individuals with undiagnosed tardive dyskinesia (TD), who experience uncontrollable facial, limb, or torso movements. The resolution urges the public to learn about TD symptoms and encourages affected individuals to consult healthcare providers for evaluation. It has no funding or policy changes - only raises awareness through Senate recognition.